Accendra Health (ACH) vs Biodesix (BDSX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Biodesix (BDSX) has outperformed Accendra Health (ACH) over the past year, gaining 261.9% versus a loss of 90.1%. Over five years, BDSX leads with a -82.4% price change compared with -98.6% for ACH. Biodesix is the larger company by market cap ($278.8 million vs $36.4 million), about 7.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACH | BDSX |
|---|---|---|
| Share price | $0.4729 | $26.42 |
| Market cap | $36.37M | $278.76M |
| 1-day change | +1.46% | -5.51% |
| YTD return | -83.11% | +288.53% |
| 1-year return | -90.07% | +261.92% |
| 5-year return | -98.56% | -82.39% |
| Forward P/E | 5.18 | — |
| EPS (TTM) | $-1.46 | $-3.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.60 | $31.97 |
| 52-week low | $0.44 | $5.26 |
| Distance from 52-week high | -91.56% | -17.36% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +41.29% |
| Average volume | 1.39M | 101.54K |
| Shares outstanding | 76.90M | 10.55M |
| Employees | — | 334 |
| Sector | Health Care | Healthcare |
| Industry | Medical Specialities | Diagnostics & Research |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Biodesix is about 7.7 times larger than Accendra Health by market value ($278.76M vs $36.37M).
- BDSX has outperformed ACH by 352.0 percentage points over the past year.
- The two companies sit in different sectors: Accendra Health in Health Care and Biodesix in Healthcare.
About Biodesix
BDSX stock →Biodesix, Inc. operates as a diagnostic solutions company.
Healthcare · Diagnostics & Research · 334 employees
ACH vs BDSX FAQ
Which is bigger, Accendra Health or Biodesix?
Biodesix (BDSX) is larger, with a market capitalization of $278.76M compared with $36.37M for Accendra Health (ACH).
Which stock has performed better over the past year, ACH or BDSX?
BDSX returned +261.92% over the past 12 months, compared with -90.07% for ACH (price return, excluding dividends). Past performance does not predict future results.
Are Accendra Health and Biodesix in the same industry?
No. Accendra Health is in the Health Care sector, while Biodesix is in Healthcare.